General Archives - Page 54 of 2367

1 minute read

Summit Therapeutics’ Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck’s Multi-Billion Keytruda In China Study

May 31, 10:21 AM

Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly improved progression-free survival in NSCLC patients compared to Keytruda.

MRK

1 minute read

Takeda Gets Positive CHMP Opinion For Recombinant ADAMTS13 In Congenital Thrombotic Thrombocytopenic Purpura

By Benzinga Newsdesk

May 31, 9:59 AM

cTTP Is an Ultra-rare, Potentially Fatal Blood-Clotting Disorder with Limited Treatment Options; Untreated, Acute TTP Events Have a Mortality Rate of >90%1,2If Approved in the European Union, rADAMTS13 Will Be the

TAK

2 minute read

Why Branded Footwear Retailer Genesco’s Shares Are Shooting Higher Today

By Shivani Kumaresan

May 31, 9:56 AM

Genesco shares surge as Q1 FY25 earnings beat estimates. Sales dropped 5.3% to $457.60M, surpassing the expected $445.05M. CEO Mimi E. Vaughn credits strategic execution amid challenges. Fiscal 2025 EPS outlook reaffirmed at $0.60 - $1.00.

GCO

1 minute read

Party Like It’s 1999: ’90s Fashion Is Making A Comeback — These Stocks Are Benefiting

By Aaron Bry

May 31, 9:32 AM

'90s fashion is making a comeback with help from social media and trendy endorsements. Companies like Abercrombie & Fitch and American Eagle are seeing strong sales, while experts suggest thrift shopping may also be on the rise.

AEO

2 minute read

BRP Down Over 3% After Q1 Earnings – Here’s Why

By Nabaparna Bhattacharya

May 31, 9:30 AM

BRP revises FY25 guidance downward, citing challenges in dealer profitability and macroeconomic conditions.

DOOO

2 minute read

Crypto Maturity Puts Pressure On Coinbase Trading Revenue

By Benzinga Neuro

May 31, 9:30 AM

The cryptocurrency market has taken a more mature turn, with price swings becoming less erratic. This shift is poised to significantly impact the revenue of major exchanges like Coinbase Global Inc. (NASDAQ:COIN).

BTC

2 minute read

Gilead’s Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer

By Vandana Singh

May 31, 9:27 AM

Gilead Sciences' announced topline results from the Phase 3 TROPiCS-04 study on Trodelvy for metastatic urothelial cancer. The study did not meet the primary endpoint of overall survival but showed numerical improvements favoring Trodelvy.

GILD

2 minute read

FDA Extends Review Deadline For Regeneron/Sanofi’s Dupixent For ‘Smoker’s Lungs’ Disease

By Vandana Singh

May 31, 9:23 AM

The FDA extends the target action date for reviewing Dupixent as an add-on treatment for uncontrolled COPD to September 27, 2024. This follows the submission of additional efficacy analyses from pivotal trials. European Medicines Agency also supports Dupixent for COPD.

REGN

2 minute read

European Commission Backs Italian State Aid To STMicroelectronics’ Chip Plant: Details

By Shivani Kumaresan

May 31, 9:09 AM

The European Commission has approved Italian state aid to support STMicroelectronics in building a €5 billion plant in Catania, Sicily. This facility will produce energy-efficient silicon carbide chips for electric vehicles. The aid includes a €2 billion direct grant. This move aims to strengthen Europe's semiconductor ecosystem and reduce reliance on imports, aligning with digital and green transition goals.

BMWYY

3 minute read

China’s ‘Decapitated’ Chip Sector Is Thrown $50B Lifeline

By Natan Ponieman

May 31, 8:44 AM

U.S.-China relations under Biden marked by efforts to block access to advanced chips. China investing $47.5B for self-reliance. Biden's measures aim for domestic production and block China's advances.

AMD